Skip to main content
. 2021 Jun 16;13(12):3009. doi: 10.3390/cancers13123009
PBMC peripheral blood mononuclear cells
HVEM herpes virus entry mediator
BTLA B and T lymphocyte attenuator
TILs tumor-infiltrating leukocytes
NSG NOD.SCID.γc-null
ICI immune checkpoint inhibitors
RNP ribonucleoproteins
DEG differentially expressed genes
GVHD graft vs. host disease
IPA ingenuity pathway analysis
GSEA gene set enrichment analysis
FDR false discovery rate
FWER family-wise error rate
PDX patient-derived xenografts
PCa prostate cancer
TCGA The Cancer Genome Atlas
PRAD prostate adenocarcinomas
PFI progression-free interval